Drugs / Detralex
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT01654016 Comparator | Aug 2012 → May 2019 | chronic venous insufficiency | University Hospital Dubrava | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Detralex | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01654016 ↗ |
| Route | Oral | “Detralex (in some countries registered as Daflon) is an oral flavonoid” NCT01654016 ↗ |